Clinical Neuroscience

[Aseptic sinus thrombosis with a predominantly benign course]

SÁTORI Mária1, GÁCS Gyula1

MAY 01, 1986

Clinical Neuroscience - 1986;39(05)

[The authors studied 7 cases of sinus thrombosis among 1390 patients in a 2-year study of a neurology department, of whom only 1 patient died. A significant proportion of patients had a coagulopathy leading to thrombosis. The authors attempt to outline the symptom clusters and unusual symptom associations that may underlie suspected benign sinus thrombosis. It is likely that fatal sinus thromboses due to various coagulation disorders may be preceded by mild attacks with a warning course similar to TIAs that predict ischaemic events. ]

AFFILIATIONS

  1. Péterfy Sándor utcai Kórház Idegosztály

COMMENTS

0 comments

Further articles in this publication

Clinical Neuroscience

The independence of cycloid psychosis from schizophrenia and affective psychosis

CARLO Perris

A short survey of the evidence supporting the independence of cycloid psychotic disorders from both schizophrenic and manic-depressive disorders is presented. Converging results from different quarters support the view that the concept of cycloid psychosis has represented a kind of blind spot in the search of a solution to a correct identification of psychotic conditions which do not fit into current conceptions of schizophrenia and of bipolar manic-depressive psychosis. A warning is also given against the identification of cycloid psychosis with schizoaffective psychosis and the risk of letting the former follow the nosological uncertainties of the latter concept.

Clinical Neuroscience

[Agoraphobic and panic neurotic patients management of respiratory control]

KOPP Mária, MIHÁLY Katalin, TRINGER Katalin, VADÁSZ Péter

[We report on a domestic adaptation of the cognitive-behavioural therapy for panic syndrome and agoraphobia with panic attacks described by Salkovskis and Clark (1984), based on the treatment of fourteen patients. During the six-week treatment period, the number and intensity of panic attacks and the level of anxiety reflecting their subjective state were significantly reduced. At the beginning of treatment, an abnormal breathing pattern was observed in the group of patients, and changes in autonomic parameters were well monitored during treatment. Among the questionnaires translated for the diagnostic study, the Anxiety and Panic Attack Diary seems to be a good measure for monitoring the effect of treatment, and the Hyperventilation Symptom List and the Marks and Mathews Fear Questionnaire may be useful tools for grouping patients. ]

Clinical Neuroscience

[Surgical outcomes of brain aneurysms ]

OROSZ Éva, VAJDA János, JUHÁSZ János, SLOWIK Felicia

[The authors evaluate the records of patients operated on for cerebral aneurysms at the National Institute of Neurosurgery over a period of 8 years (1977-1984) using computer processing. The overall mortality of 894 operations is 15%. They examined the role of patient age, sex, preoperative status, aneurysm location, time between bleeding and surgery, and surgical complications, as well as spasm on angiography, in the outcome and evaluated the sectional findings of patients who died. Special attention was paid to the evaluation of late ischaemic complications. The most important factor for surgical outcome appears to be the patient's preoperative condition and the appropriate timing of surgery. ]

Clinical Neuroscience

[The dexamethasone suppression test in psychiatric practice ]

SZÁDÓCZKY Erika, ARATÓ Mihály, RIHMER Zoltán, MOUSSONG-KOVÁCS Erzsébet

[The authors examined dexamethasone suppression test results in 186 patients diagnosed according to DSM III criteria and treated in an open psychiatric ward. The test was found to have a relatively high sensitivity (61%) and a relatively low specificity (64%) for major depression. Abnormal test results above those reported in healthy individuals were observed in a group of patients with dysthymia and panic. A close association of these two categories with major affective disorder is assumed.]

All articles in the issue

Related contents

Lege Artis Medicinae

[Focus on Lege Artis Medicinae (LAM)]

VASAS Lívia, GEGES József

[Three decades ago, LAM was launched with the goal of providing scientific information about medicine and its frontiers. From the very beginning, LAM has also concerned a special subject area while connecting medicine with the world of art. In the palette of medical articles, it remained a special feature to this day. The analysis of the history of LAM to date was performed using internationally accepted publication guidelines and scientific databases as a pledge of objectivity. We examined the practice of LAM if it meets the main criteria, the professional expectations of our days, when publishing contents of the traditional printed edition and its electronic version. We explored the visibility of articles in the largest bibliographic and scientific metric databases, and reviewed the LAM's place among the Hun­ga­rian professional journals. Our results show that in recent years LAM has gained international reputation des­pite publishing in Hungarian spoken by a few people. This is due to articles with foreign co-authors as well as references to LAM in articles written exclusively by foreign researchers. The journal is of course full readable in the Hungarian bibliographic databases, and its popularity is among the leading ones. The great virtue of the journal is the wide spectrum of the authors' affiliation, with which they cover almost completely the Hungarian health care institutional sys­tem. The special feature of its columns is enhanced by the publication of writings on art, which may increase Hungarian and foreign interest like that of medical articles.]

Clinical Neuroscience

A variant of Guillain-Barre syndrome after SARS-CoV-2 vaccination: AMSAN

TUTAR Kaya Nurhan, EYIGÜRBÜZ Tuğba, YILDIRIM Zerrin, KALE Nilufer

Introduction - Coronavirus disease 2019 (COVID-19) is a respiratory infection that has rapidly become a global pandemic and vaccines against SARS-CoV-2 have been developed with great success. In this article, we would like to present a patient who developed Guillain-Barré syndrome (GBS), which is a serious complication after receiving the inactive SARS-CoV-2 vaccine (CoronaVac). Case report – A 76-year-old male patient presented to the emergency department with nine days of progressive limb weakness. Two weeks prior to admission, he received the second dose of CoronaVac vaccine. Motor examination revealed decreased extremity strength with 3/5 in the lower extremities versus 4/5 in the upper extremities. Deep tendon reflexes were absent in all four extremities. Nerve conduction studies showed predominantly reduced amplitude in both motor and sensory nerves, consistent with AMSAN (acute motor and sensory axonal neuropathy). Conclusion - Clinicians should be aware of the neuro­logical complications or other side effects associated with COVID-19 vaccination so that early treatment can be an option.

Clinical Neuroscience

Matrix metalloproteinases and their tissue inhibitors in relapsing remitting multiple sclerosis: Possible markers and treatment agents

SANLI Arzu, OZTURK Musa, SOYSAL Aysun, DOVENTAS Yasemin, BASOGLU Fulya, GOZUBATIK-CELIK R. Gokcen, BAYBAS Sevim

Matrix metalloproteinases (MMPs), which are synthesized by many cell groups and responsible for the destruction of matrix proteins, and endogen tissue inhibitors of MMPs (TIMPs) have a role in the pathogenesis of Multiple Sclerosis (MS) by affecting the blood-brain barrier. We aimed to investigate the role of MMPs and TIMPs in the immunopathogenesis and in the course of multiple sclerosis (MS). We enrolled 25 relapsing remitting MS patients, who had a definite MS diagnosis according to McDonald criteria and 25 healthy subjects similar for age and gender as control group. MMP-9- and TIMP-1 levels were measured twice in patient group (one time during an attack and one in remission) and once in healthy subjects. MMP-9- and TIMP-levels of patients during attack and remission period and MMP-9/TIMP-1 ratio were found significantly higher than in the control subjects. In patient group MMP-9 and TIMP-1 levels and MMP-9/TIMP-1 ratio during attacks were not significantly different than during remission period. However, when subdivided according to their number of attacks, patients with 2 attacks had significantly higher levels during attack period comparing to remission period (p<0.05); in case of patients with more than 2 attacks did not have a statistically significant difference in attack and remission periods. Matrix metalloproteinases are important actors in MS immunopathogenesis, particularly in the early period and inhibitor agents for these enzymes can be used as a treatment option.

Clinical Neuroscience

[Treatment and new evidences in neuromyelitis optica spectrum disorder ]

ILLÉS Zsolt

[Treatment and new evidences in neuromyelitis optica spectrum disorder Illés Zs, MD, PhD Ideggyogy Sz 2021;74(9–10):309–321. Neuromyelitis optica spectrum disorder (NMOSD) is associated with antibodies against AQP4 in about 80% of the cases. In about one-fourth of seronegative cases, antibodies against the MOG protein are present in the serum (MOG-antibody associated disease, MOGAD). This article discusses off-label azathioprine and mycophenolate mofetil in the treatment of NMOSD and reviews the evidence-based clinical aspects of B/plasma cell depletion, antagonization of IL-6 signaling and blocking the complement pathway. The review also summarizes basic aspects of NMOSD pregnancy focusing on treatment, and the different therapeutic approach in MOGAD. In the recent two years, phase 3 clinical trials provided class I evidence for the efficacy and safety of rituximab (anti-CD20), inebilizumab (anti-CD19), tocilizumab (anti-IL6R), satralizumab (anti-IL6R), and eculizumab (anti-C5) in combination with other immunosuppressants or in monotherapy. The treatment approach in MOGAD is complicated by the monophasic course in about half of the cases and by the potential disappearance of MOG antibody. The necessity of maintenance treatment in MOGAD should be decided after tapered oral steroid. Immunosuppression is recommended in NMOSD during pregnancy and lactation, and this should be considered for optimal selection of treatment in fertile female patients. The new monoclonal antibodies broadened treatment options NMOSD, and the treatment strategy of MOGAD has become more straightforward.]

Clinical Neuroscience

To handle the HaNDL syndrome through a case: The syndrome of headache with neurologic deficits and cerebrospinal fluid lymphocytosis

ÇOBAN Eda, TEKER Ruken Serap, SERİNDAĞ Helin, SAKALLI Nazan, SOYSAL Aysun

The syndrome of headache with neurologic deficits and cerebrospinal fluid lymphocytosis (HaNDL) is a rare entity. This disease has been related to migrainous headaches. It is a benign, self-limited disorder, which is characterized by fluctuating neurological symptoms and cerebrospinal fluid lymphocytosis. We describe a case of a 47 years old man with acute onset of headache and aphasia. Cerebrospinal fluid analysis revealed a lymphocytic pleocytosis (25 cells/μl, 100% lymphocytes). Electroencephalogram showed moderate slow rhythm in the left hemisphere, with temporoparietal predominance, and without epileptiform activity. His blood tests as well as magnetic resonance imaging (MRI) results were normal. With the diagnosis of HaNDL syndrome the patient was accepted in the Department of Neurology and discharged with full recovery.